[Central serous chorioretinopathy: A review]

E Bousquet; J Provost; H Torres-Villaros; F Behar-Cohen

doi:10.1016/j.jfo.2023.02.003

[Central serous chorioretinopathy: A review]

J Fr Ophtalmol. 2023 Sep;46(7):791-802. doi: 10.1016/j.jfo.2023.02.003. Epub 2023 Jun 3.

[Article in French]

Authors

E Bousquet¹, J Provost², H Torres-Villaros², F Behar-Cohen³

Affiliations

¹ Départment d'ophtalmologie, hôpital Lariboisière, Assistance publique-Hôpitaux de Paris (AP-HP), université de Paris Cité, Paris, France. Electronic address: [email protected].
² Départment d'ophtalmologie, ophtalmopôle, hôpital Cochin, Assistance publique-Hôpitaux de Paris (AP-HP), université de Paris Cité, Paris, France.
³ Départment d'ophtalmologie, ophtalmopôle, hôpital Cochin, Assistance publique-Hôpitaux de Paris (AP-HP), université de Paris Cité, Paris, France; Centre de recherche des cordeliers, université de Paris Cité, Inserm, From physiopathology of retinal diseases to clinical advances, 75006 Paris, France.

PMID: 37277234
DOI: 10.1016/j.jfo.2023.02.003

Abstract

The central serous chorioretinopathy (CSCR) is characterized by serous retinal detachments SRD associated with one or several retinal pigment epithelium detachments/irregularities (PEDs). The choroid is thickened with dilated choroidal veins and choroidal hyperpermeability suggesting an underlying choroidopathy. CSCR belongs to the pachychoroid spectrum. CSCR affects mostly middle-aged men and the main risk factor is the corticosteroid intake. In most cases, the subretinal detachment resolves spontaneously with a good visual prognosis. However, recurrent or chronic form of the disease can lead to irreversible retinal damage and decreased visual acuity. Laser on an extra foveal leak point or half dose/half fluence photodynamic therapy are the first-line treatment options.

Keywords: Central serous chorioretinopathy; Choriorétinopathie séreuse centrale; Choroidopathy; Choroïdopathie; Décollement de l’épithélium pigmentaire; Décollement séreux rétinien; Laser; Photodynamic therapy; Photothérapie dynamique; Pigment epithelium detachment; Serous retinal detachment.

Publication types

English Abstract
Review

MeSH terms

Central Serous Chorioretinopathy* / complications
Central Serous Chorioretinopathy* / diagnosis
Central Serous Chorioretinopathy* / epidemiology
Chronic Disease
Fluorescein Angiography
Humans
Male
Middle Aged
Retina
Retinal Detachment* / diagnosis
Retinal Detachment* / etiology
Retinal Detachment* / therapy
Retrospective Studies
Tomography, Optical Coherence